These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33735065)

  • 41. Assessment of cardiac dimensions in children diagnosed with hypertrophic cardiomyopathy.
    Bakaya K; Paracha W; Schievano S; Bozkurt S
    Echocardiography; 2022 Sep; 39(9):1233-1239. PubMed ID: 35978451
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy.
    O'Mahony C; Tome-Esteban M; Lambiase PD; Pantazis A; Dickie S; McKenna WJ; Elliott PM
    Heart; 2013 Apr; 99(8):534-41. PubMed ID: 23339826
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Semiautomatic detection of myocardial contours in order to investigate normal values of the left ventricular trabeculated mass using MRI.
    Bricq S; Frandon J; Bernard M; Guye M; Finas M; Marcadet L; Miquerol L; Kober F; Habib G; Fagret D; Jacquier A; Lalande A
    J Magn Reson Imaging; 2016 Jun; 43(6):1398-406. PubMed ID: 26646347
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictive Values of Apelin for Myocardial Fibrosis in Hypertrophic Cardiomyopathy.
    Zhou Y; Yuan J; Wang Y; Qiao S
    Int Heart J; 2019 May; 60(3):648-655. PubMed ID: 31019180
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MRI and cine MRI of asymmetric septal hypertrophic cardiomyopathy.
    Arrivé L; Assayag P; Russ G; Najmark D; Brochet E; Nahum H
    J Comput Assist Tomogr; 1994; 18(3):376-82. PubMed ID: 8188902
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy.
    Smole T; Žunkovič B; Pičulin M; Kokalj E; Robnik-Šikonja M; Kukar M; Fotiadis DI; Pezoulas VC; Tachos NS; Barlocco F; Mazzarotto F; Popović D; Maier L; Velicki L; MacGowan GA; Olivotto I; Filipović N; Jakovljević DG; Bosnić Z
    Comput Biol Med; 2021 Aug; 135():104648. PubMed ID: 34280775
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Athlete's heart in women. Echocardiographic characterization of highly trained elite female athletes.
    Pelliccia A; Maron BJ; Culasso F; Spataro A; Caselli G
    JAMA; 1996 Jul; 276(3):211-5. PubMed ID: 8667565
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advanced myocardial characterization in hypertrophic cardiomyopathy: feasibility of CMR-based feature tracking strain analysis in a case-control study.
    Yang L; Zhang L; Cao S; Gao C; Xu H; Song T; Zhang X; Wang K
    Eur Radiol; 2020 Nov; 30(11):6118-6128. PubMed ID: 32588208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Automated Echocardiographic Quantification of Left Ventricular Ejection Fraction Without Volume Measurements Using a Machine Learning Algorithm Mimicking a Human Expert.
    Asch FM; Poilvert N; Abraham T; Jankowski M; Cleve J; Adams M; Romano N; Hong H; Mor-Avi V; Martin RP; Lang RM
    Circ Cardiovasc Imaging; 2019 Sep; 12(9):e009303. PubMed ID: 31522550
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictors of Outcome After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: An Echocardiography and Cardiovascular Magnetic Resonance Imaging Study.
    Lu M; Du H; Gao Z; Song L; Cheng H; Zhang Y; Yin G; Chen X; Ling J; Jiang Y; Wang H; Li J; Huang J; He Z; Zhao S
    Circ Cardiovasc Interv; 2016 Mar; 9(3):e002675. PubMed ID: 26884612
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Left ventricular short-axis plane for magnetic resonance imaging: its clinical importance and applications].
    Suzuki J; Sakamoto T; Kawakubo K; Hada Y; Amano K; Takenaka K; Hasegawa I; Shiota T; Sugimoto T; Nishikawa J
    J Cardiol; 1987 Jun; 17(2):249-58. PubMed ID: 3448166
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predicting the development of adverse cardiac events in patients with hypertrophic cardiomyopathy using machine learning.
    Kochav SM; Raita Y; Fifer MA; Takayama H; Ginns J; Maurer MS; Reilly MP; Hasegawa K; Shimada YJ
    Int J Cardiol; 2021 Mar; 327():117-124. PubMed ID: 33181159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relation between left ventricular outflow tract obstruction and left ventricular shape in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
    Martin R; Lairez O; Boudou N; Méjean S; Lhermusier T; Dumonteil N; Berry M; Cognet T; Massabuau P; Elbaz M; Rousseau H; Galinier M; Carrié D
    Arch Cardiovasc Dis; 2013; 106(8-9):440-7. PubMed ID: 23906680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The influence of age on gender-specific differences in the left ventricular cavity size and contractility in patients with hypertrophic cardiomyopathy.
    Dimitrow PP; Czarnecka D; Kawecka-Jaszcz K; Dubiel JS
    Int J Cardiol; 2003 Mar; 88(1):11-6; discussion 16-7. PubMed ID: 12659978
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identifying Ventricular Arrhythmias and Their Predictors by Applying Machine Learning Methods to Electronic Health Records in Patients With Hypertrophic Cardiomyopathy (HCM-VAr-Risk Model).
    Bhattacharya M; Lu DY; Kudchadkar SM; Greenland GV; Lingamaneni P; Corona-Villalobos CP; Guan Y; Marine JE; Olgin JE; Zimmerman S; Abraham TP; Shatkay H; Abraham MR
    Am J Cardiol; 2019 May; 123(10):1681-1689. PubMed ID: 30952382
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Helical distribution of hypertrophy in patients with hypertrophic cardiomyopathy: prevalence and clinical implications.
    Viliani D; Pozo E; Aguirre N; Cecconi A; Olivera MJ; Caballero P; Jiménez-Borreguero LJ; Alfonso F
    Int J Cardiovasc Imaging; 2017 Nov; 33(11):1771-1780. PubMed ID: 28536896
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Global Longitudinal Strain and Left Atrial Volume Index Provide Incremental Prognostic Value in Patients With Hypertrophic Cardiomyopathy.
    Hiemstra YL; Debonnaire P; Bootsma M; van Zwet EW; Delgado V; Schalij MJ; Atsma DE; Bax JJ; Marsan NA
    Circ Cardiovasc Imaging; 2017 Jul; 10(7):. PubMed ID: 28679523
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Serial changes in left ventricular configuration and function in hypertrophic cardiomyopathy].
    Horita Y; Genda A; Shimizu Y; Sugihara N; Suematsu T; Kita Y; Takeda R
    J Cardiol; 1988 Sep; 18(3):651-64. PubMed ID: 3249282
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy.
    Eberly LA; Day SM; Ashley EA; Jacoby DL; Jefferies JL; Colan SD; Rossano JW; Semsarian C; Pereira AC; Olivotto I; Ingles J; Seidman CE; Channaoui N; Cirino AL; Han L; Ho CY; Lakdawala NK
    JAMA Cardiol; 2020 Jan; 5(1):83-91. PubMed ID: 31799990
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relation of strain by feature tracking and clinical outcome in children, adolescents, and young adults with hypertrophic cardiomyopathy.
    Smith BM; Dorfman AL; Yu S; Russell MW; Agarwal PP; Ghadimi Mahani M; Lu JC
    Am J Cardiol; 2014 Oct; 114(8):1275-80. PubMed ID: 25159233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.